Application progress of temozolomide in clinical tumor chemotherapy
<p>Temozolomide is an imidazotetrazine derivative of the alkylating agent, which is used to treat central nervous system tumors, especially malignant brain gliomas. It is a milestone in brain giloma chemotherapy. Recently, some researchers used temozolomide for the treatment of other tumors, i...
Main Authors: | Cheng ZHONG, Bin WANG, Sheng-qing LV |
---|---|
Format: | Article |
Language: | English |
Published: |
Tianjin Huanhu Hospital
2013-12-01
|
Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
Subjects: | |
Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/867 |
Similar Items
-
Progress of temozolomide in the treatment of recurrent high-grade gliomas
by: Jin-duo LI, et al.
Published: (2013-12-01) -
Application and advance of temozolomide in the treatment of pituitary adenomas
by: Yi-guang LIN, et al.
Published: (2015-12-01) -
OUTCOME OF CHILDREN WITH RETINOBLASTOMA TREATED WITH PRIMARY CHEMOTHERAPY
by: Tariq Muhammad Saeed, et al.
Published: (2019-03-01) -
Systematic review of catatonia treatment
by: Pelzer ACM, et al.
Published: (2018-01-01) -
Study on synergistic effect of Rac1 inhibitor and temozolomide in inhibiting proliferation and invasiveness of glioma cells in vitro
by: Xiao-yong HAN, et al.
Published: (2016-08-01)